HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$1.81
Day range
$1.76 - $2.06
Year range
$0.89 - $3.19
Market cap
59.41M USD
Avg Volume
303.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.37M | 128.93% |
Net income | -4.53M | -12.85% |
Net profit margin | — | — |
Earnings per share | -0.16 | 27.27% |
EBITDA | -4.35M | 0.51% |
Effective tax rate | -2.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.07M | -28.36% |
Total assets | 11.62M | -20.26% |
Total liabilities | 5.84M | -1.53% |
Total equity | 5.78M | — |
Shares outstanding | 29.56M | — |
Price to book | 9.05 | — |
Return on assets | -91.99% | — |
Return on capital | -151.93% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.53M | -12.85% |
Cash from operations | -3.82M | -6.55% |
Cash from investing | — | — |
Cash from financing | 2.40M | 1,744.05% |
Net change in cash | -1.31M | -13.73% |
Free cash flow | -2.45M | 7.85% |
About
Founded
2017
Website
Employees
24
